Literature DB >> 1444575

Further evidence that acanthosis nigricans maligna is linked to enhanced secretion by the tumour of transforming growth factor alpha.

K Wilgenbus1, A Lentner, R Kuckelkorn, S Handt, C Mittermayer.   

Abstract

The pathogenesis of cutaneous paraneoplastic syndromes is still under discussion. Since many of these syndromes, including acanthosis nigricans, are proliferative skin disorders it is believed that products secreted by the tumour stimulate the keratinocytes to proliferate. Growth factors like transforming growth factor alpha (TGF-alpha) are known to be highly mitogenic for keratinocytes in vitro. Here we report on a patient with a poorly differentiated gastric cancer and a full clinical picture of acanthosis nigricans characterized by diffuse hyperkeratosis and multiple papillomatous lesions of the skin with involvement of the conjunctivae. In Southern blot analysis of the tumour tissue from this patient amplification of the epidermal growth factor (EGF) receptor, the common ligand for TGF-alpha and EGF, was shown. Immunohistochemically, prominent staining was found throughout the tumour using anti-TGF-alpha antibodies. In a series of 25 investigated gastric tumour biopsies, four tumours showed amplification of the EGF receptor and one additional biopsy was positive for TGF-alpha. Since there is no other report describing the link between TGF-alpha and acanthosis nigricans, except that of Ellis et al. 1987, we present a new case suggesting a possible link between growth factors and acanthosis nigricans maligna.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444575     DOI: 10.1007/bf00372579

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

1.  Classification of acanthosis nigricans.

Authors:  H O Curth
Journal:  Int J Dermatol       Date:  1976-10       Impact factor: 2.736

Review 2.  Transforming growth factor alpha.

Authors:  R Derynck
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

3.  Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes.

Authors:  D L Ellis; S P Kafka; J C Chow; L B Nanney; W H Inman; M E McCadden; L E King
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

Review 4.  The EGF/TGF alpha receptor in skin.

Authors:  L E King; R E Gates; C M Stoscheck; L B Nanney
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

5.  Improvement of oral lesions associated with malignant acanthosis nigricans after treatment of lung cancer.

Authors:  K Nomachi; M Mori; N Matsuda
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1989-07

6.  Generalized malignant acanthosis nigricans.

Authors:  G R Mikhail; D M Fachnie; B H Drukker; R Farah; H M Allen
Journal:  Arch Dermatol       Date:  1979-02

Review 7.  Growth factors in progression of human esophageal and gastric carcinomas.

Authors:  K Yoshida; W Yasui; H Ito; E Tahara
Journal:  Exp Pathol       Date:  1990

8.  v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.

Authors:  J P Falco; S B Baylin; R Lupu; M Borges; B D Nelkin; R K Jasti; N E Davidson; M Mabry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

9.  Malignant acanthosis nigricans associated with non-Hodgkin's lymphoma. Report of 2 cases.

Authors:  M Janier; C Blanchet-Bardon; D Bonvalet; M Lenoble; F Boiget; J Civatte
Journal:  Dermatologica       Date:  1988

10.  Acanthosis nigricans maligna. Clinical and virological investigations.

Authors:  G Gross; H Pfister; B Hellenthal; M Hagedorn
Journal:  Dermatologica       Date:  1984
View more
  4 in total

1.  Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus.

Authors:  S Koyama; K Ikeda; M Sato; K Shibahara; K Yuhara; H Fukutomi; K Fukunaga; N Kanazawa; K Yuzawa; K Fukao; T Iijima; M Kikuchi; T Tomiya; K Fujiwara
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

2.  Malignant Acanthosis Nigricans Associated with Ovarian Cancer.

Authors:  Chee Won Oh; Jimi Yoon; Chi Yeon Kim
Journal:  Case Rep Dermatol       Date:  2010-07-02

3.  Malignant acanthosis nigricans associated with prostate cancer: a case report.

Authors:  Joanna Kubicka-Wołkowska; Sylwia Dębska-Szmich; Maja Lisik-Habib; Marcin Noweta; Piotr Potemski
Journal:  BMC Urol       Date:  2014-11-15       Impact factor: 2.264

4.  Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Authors:  Julia Kneissl; Anja Hartmann; Nicole Pfarr; Franziska Erlmeier; Thomas Lorber; Simone Keller; Gwen Zwingenberger; Wilko Weichert; Birgit Luber
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-08       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.